Read articles from Global
November 17, 2026 by oup.com
Trends in social norms toward smoking and vaping from 2016 to 2022: findings from the ITC Four Country Smoking and Vaping Surveys
Attitudes towards smoking and vaping are moving in opposite directions, according to new research published in Nicotine & Tobacco Research.
An analysis of nearly 20,000 participants in England, Australia, Canada and the United States found that, between 2016 and 2022, disapproval of smoking declined while negative attitudes towards vaping increased significantly.
Researchers warn that these trends could discourage smokers from switching to lower-risk alternatives, although their impact on quitting behaviour remains uncertain. The findings underline the importance of accurate risk communication and greater public understanding of the differences between smoking and vaping.
November 10, 2026 by medium.com
How People Perceive Risks
People do not always assess risk according to scientific evidence. Psychological research shows that unfamiliar, invisible and uncontrollable threats often generate greater fear than well-known dangers, even when their actual risks are lower.
This helps explain why newer nicotine products can be perceived as more dangerous than cigarettes, despite substantially reducing exposure to many harmful toxicants.
Understanding how people perceive risk is essential to tobacco harm reduction. Public health communication must address both the scientific evidence and the psychological factors shaping consumer decisions.
November 05, 2026 by medium.com
Time for a research priorities reset
Smoking-related deaths in the United States remain concentrated among older adults, yet this population receives comparatively little attention in tobacco control research.
While teenage smoking has fallen to historic lows and youth vaping has declined substantially, smoking rates among older adults are improving more slowly.
The contrast raises important questions about research priorities and the allocation of public health resources. Greater attention to older smokers, effective cessation support and access to lower-risk nicotine alternatives could help address the population bearing the greatest burden of smoking-related disease.
October 21, 2026 by medium.com
Teen Nicotine Use is at a 50-Year Low
Nicotine use among American teenagers may be at its lowest level in 50 years, according to an analysis of long-term national survey data by Charles A. Gardner.
Youth cigarette smoking has declined dramatically, while vaping has also fallen substantially in recent years. Although differences in historical survey methods make the exact 50-year comparison uncertain, the overall downward trend is clear.
These findings offer important context for tobacco harm reduction, highlighting the need to recognise progress in youth prevention while maintaining access to lower-risk alternatives for adults who smoke.
October 16, 2026 by dcjournal.com
Counterpoint: A New Generation of the Same Old Mistake
Generational nicotine bans are gaining attention despite declining youth smoking and vaping rates in the United States. Critics argue that extending restrictions into adulthood could encourage illicit trade, limit consumer choice and undermine access to lower-risk nicotine products.
Experiences with tobacco prohibitions in Massachusetts and Bhutan illustrate the potential unintended consequences of restrictive policies. Protecting young people remains essential, but effective regulation should also recognise differences in product risk and preserve opportunities for adults to move away from combustible tobacco.
October 08, 2026 by youtube.com
What are nicotine pouches?
What is inside a nicotine pouch matters because consumers deserve to understand the products they use. Beyond nicotine, pouches typically contain plant-based fibres, pH adjusters, flavourings, sweeteners and stabilisers that affect how the product feels, tastes and delivers nicotine. That does not make them risk-free, but it does make them very different from cigarettes, where burning tobacco creates thousands of toxic chemicals. Better public health communication should explain product contents clearly, rather than leaving nicotine pouches to be judged by suspicion alone.
October 07, 2026 by substack.com
She Was Told to Smoke. Then She Was Told to Stop Trying to Quit.
She was first told to smoke, then judged for needing a way out. That contradiction captures a long public health failure: people were encouraged into cigarettes by culture, marketing and social norms, then later treated as the problem when they struggled to quit. Harm reduction starts from a more humane place. It recognises dependence, history and circumstance, and gives people safer routes away from combustion without turning their past into a moral verdict.
October 07, 2026 by medium.com
Why “Safer” Matters
“Safer” is not a loophole in public health; it is the point of harm reduction. For people who cannot or will not stop using nicotine immediately, the difference between burning tobacco and using a lower-risk product can be the difference between continued exposure and meaningful risk reduction. Demanding “safe” before accepting “safer” leaves cigarettes with an advantage they do not deserve. Public health should care about every step that moves people away from the most harmful option.
September 30, 2026 by quitlikesweden.org
Growing evidence supports nicotine pouches as an alternative to smoking
The evidence base for nicotine pouches is becoming harder to dismiss as a niche issue. As smoke-free, non-combustible products, pouches may offer adult smokers another route away from cigarettes, particularly where acceptability and everyday use matter. Their role should be assessed through toxicology, switching behaviour and population-level impact rather than moral discomfort with nicotine. A credible tobacco policy should ask whether these products reduce exposure to the harms of smoking — and regulate them accordingly.
September 29, 2026 by gfn.tv
New Nicotine Products & Cardiovascular Health: What Does the Evidence Say? | #GFN26 Science Lab
Cardiovascular risk is one of the places where nicotine policy needs the most precision. New nicotine products should be assessed by what they do to exposure, biomarkers and real-world switching, not by assuming every product carries the same risk as smoking. Cigarettes remain uniquely harmful because combustion drives a major share of cardiovascular damage. The evidence debate should help smokers understand relative risk clearly, while still recognising uncertainty where the science is still developing.
- Page 1 of 168